Viewing nowDapa Tablets (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

MFDS item code 202203322 · Approved 2022.08.19 · Insurance code 644309700
Control of type 2 diabetes, prevention of worsening chronic heart failure, and inhibition of chronic kidney disease progression
This medication is used in conjunction with diet and exercise to improve blood sugar control in patients with type 2 diabetes. Additionally, for patients with chronic heart failure, it helps reduce the risks of death, hospitalization due to cardiovascular disease, and emergency hospital visits. In patients with chronic kidney disease, it is used in combination with other treatments to reduce the risk of kidney function decline and cardiovascular-related mortality. Thus, this medication improves various risks associated with diabetes, heart failure, and kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of treatment with diabetes medications, when this medicine is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dosage adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dosage adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in patients with known allergies to the active ingredient or excipients, or in those with type 1 diabetes or diabetic ketoacidosis. It also contains anhydrous lactose, which is contraindicated in patients with galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndromes. Use in patients undergoing dialysis is also not recommended. This drug should be used with caution in patients with reduced fluid volume or impaired kidney function, and fluid status and renal function should be assessed before administration. Caution is particularly necessary for older adults or patients on diuretics, as they may be at higher risk of hypotension or decreased intravascular volume. In patients with moderate or severe renal impairment, blood sugar control effects may be diminished, and administration is not recommended for those with severely impaired kidney function. During treatment, genital infections and urinary tract infections may occur; immediate treatment should be sought if symptoms arise. There is a risk of hypoglycemia, so dosage adjustments may be necessary when used concomitantly with insulin or sulfonylureas. Symptoms of dehydration or hypotension can occur due to fluid volume reduction, so medical advice should be sought if symptoms appear. Diabetic ketoacidosis can rarely occur, so patients should immediately notify healthcare providers if they experience symptoms such as vomiting, abdominal pain, or breathlessness. This medication should be used cautiously in patients with severely impaired liver function and is not recommended for use in pregnant or breastfeeding women. Elderly patients are at increased risk for decreased renal function and fluid volume reduction, so extra caution is necessary. Glucose may be detected in urine tests while taking this medication, but this is a normal response. In the case of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms. Care should be taken when driving or operating machinery considering the risk of hypoglycemia. This medication should be stored out of reach of children and kept in its original container for safety.
Vulvovaginitis, balanitis and related genitourinary infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, elevated serum creatinine at the beginning of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, biliary stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, gastroesophageal reflux disease, upper abdominal pain, diverticulosis, intestinal perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, sensory disturbances, nerve compression, sinusitis, diverticulitis, pelvic inflammatory disease, pneumonia, pulmonary tuberculosis, ligament sprain, road accident, drug overdose, ankle fracture, hand fracture, iliac bone fracture, meniscus injury, thoracic vertebra fracture, tibial fracture, anxiety disorder, enuresis, vertigo, tinnitus, palpitations, insomnia, fatty liver, gallbladder polyp, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased appetite, thirst, taste disturbances, nasopharyngitis, upper respiratory infection, chest pain, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, menstrual irregularities, pruritus, urticaria, cold sweats, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect against air and moisture, and it is safe to store at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's efficacy for a longer duration.
Yellow, biconvex, diamond-shaped film-coated tablets
30 tablets/box [(10 tablets/PTP×3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.